The Protocol Review and Monitoring System (PRMS) consists of the Protocol Review and Monitoring Committee and the disease-specific Clinical Working Groups. It prioritizes and approves the clinical research not only at UNMCC but throughout the New Mexico Cancer Care Alliance (NMCCA). The PRMS:
Teresa Rutledge, MD, an expert in gynecologic oncology, leads the Protocol Review and Monitoring System. She chairs the Protocol Review and Monitoring Committee of the UNM Cancer Center and the NMCCA. Dr. Rutledge is an Associate Professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology. In 2014, Dr. Rutledge received the NCI Cancer Clinical Investigator Team Leadership Award. Dr. Rutledge serves on the UNM Health Sciences Center Scientific Review Committee and is a member of the UNM Cancer Center Data Safety Monitoring Committee. At the national level Dr. Rutledge has served on number of GOG Committees, including cervical cancer, developmental therapeutics, and health outcomes research.
The UNM Cancer Center PRMS is the state’s PRMS. It is designed to deliver clinical research to the entire state of New Mexico through the NMCCA, the statewide cancer clinical trials network. Consequently, the Protocol Review and Monitoring Committee is comprised of members from UNM Cancer Center and the NMCCA sites.
Clinical Working Groups at UNM Cancer Center review and prioritize protocols based on their:
Clinical Working Groups recommend protocols to the Protocol Review and Monitoring Committee for further review. The responsibilities of the Protocol Review and Monitoring Committee are to: